BASF stock holds after earnings and guidance updates

BASF (ISIN DE000BASF111) is still framed by its latest full-year numbers: sales of EUR 65.3 billion in 2025 and EBITDA before special items of EUR 7.9 billion, while the company continued to guide for 2026 conditions across its investor materials. The latest BASF investor relations page remains the main source for that framework.

EUR 65.3 billion sets the scale

BASF reported 2025 sales of EUR 65.3 billion, against EUR 68.9 billion in the prior year, which shows a decline of EUR 3.6 billion year on year. EBITDA before special items came in at EUR 7.9 billion in 2025, compared with EUR 8.0 billion in 2024, a narrower drop that matters more for margin tracking than the top line alone.

For investors, that comparison is the key reference point until the next quarterly update. The company also reported free cash flow of EUR 0.7 billion in 2025, which gives a cleaner read on operating resilience than headline sales alone.

Margins still do the work

The 2025 EBITDA margin before special items was 12.1%, based on sales of EUR 65.3 billion and EBITDA before special items of EUR 7.9 billion. That margin is the figure that links BASF stock most directly to execution, because it captures whether lower sales are being offset by cost control and portfolio mix.

Net income reached EUR 1.3 billion in 2025, after EUR 225 million in 2024, a year-on-year increase of EUR 1.075 billion. The swing is one of the clearest comparisons in the latest report set, and it is more informative than a simple sales snapshot.

Cash flow and debt

Free cash flow of EUR 0.7 billion in 2025 mattered because BASF had to preserve balance-sheet flexibility while managing a lower revenue base. Net debt stood at EUR 15.1 billion at year-end 2025, which remains a central figure for any valuation read-through.

That combination of EUR 0.7 billion free cash flow and EUR 15.1 billion net debt leaves the market focused on cash conversion, not only earnings. A first.

Performance chemicals matter

BASF has long described Performance Chemicals as one of the groups that can help stabilize margins when broader industrial demand softens. The relevance for BASF stock is not the product category alone, but whether it supports the 12.1% EBITDA margin before special items that the company posted for 2025.

That is why the market reads segment details alongside company-wide numbers. If sales stay at EUR 65.3 billion while EBITDA before special items improves from EUR 7.9 billion, the operating mix is doing more of the work than volume growth.

Stock level and market view

BASF shares on Xetra are best judged against the company results already on record, rather than against a fresh intraday quote that is not part of the available evidence set here. The dated reference points remain the 2025 sales figure of EUR 65.3 billion, the 2025 EBITDA before special items figure of EUR 7.9 billion, and the EUR 15.1 billion net debt figure at year-end 2025.

Those numbers frame the current valuation debate more clearly than an isolated price print. BASF stock therefore remains a cash-flow and margin story, with EUR 0.7 billion free cash flow in 2025 and a year-on-year net income swing from EUR 225 million to EUR 1.3 billion doing most of the analytical work.

Investor relations anchor

The BASF investor relations site keeps the full report set in one place, including the annual numbers, presentation material, and subsequent company updates. That makes it the most relevant reference point for monitoring whether the 2026 outlook changes the 2025 baseline of EUR 65.3 billion in sales and EUR 7.9 billion in EBITDA before special items.

Latest reported baseline

The latest reported baseline shows why BASF stock is usually read through earnings quality first: sales, EBITDA before special items, free cash flow, and net debt all point to the same operating question. On the figures already published for 2025, the company had EUR 65.3 billion in sales, EUR 7.9 billion in EBITDA before special items, EUR 0.7 billion in free cash flow, and EUR 15.1 billion in net debt.

That is a tight set of metrics for a cyclical chemical group. The comparison that stands out most is net income, which rose from EUR 225 million in 2024 to EUR 1.3 billion in 2025, a gain of EUR 1.075 billion.

Chemical portfolio check

The chemicals portfolio matters because it links industrial demand to margin discipline. For BASF, the 2025 numbers suggest that portfolio mix, cost control, and cash conversion mattered more than a simple rebound in revenue.

That is the practical takeaway from the latest company figures. BASF stock is being judged on whether the group can keep EBITDA before special items close to EUR 7.9 billion or better while reducing the pressure from EUR 15.1 billion of net debt.

How the year compares

On a year-on-year basis, the company posted a revenue decline of EUR 3.6 billion, from EUR 68.9 billion in 2024 to EUR 65.3 billion in 2025. At the same time, net income improved by EUR 1.075 billion, from EUR 225 million to EUR 1.3 billion, which is the kind of comparison that changes how markets read the cycle.

That contrast between lower sales and higher profit is the most useful fact pattern in the current evidence set. It suggests that BASF stock is not being priced only on volume, but on profitability and capital discipline.

Cash generation matters most

Free cash flow of EUR 0.7 billion in 2025 remains the number that bridges earnings and balance-sheet strength. A chemical company can survive a sales dip more comfortably when it still generates cash, even if the level is modest relative to the scale of the group.

Net debt of EUR 15.1 billion keeps that point in view. The market will continue to watch whether future reporting improves cash generation faster than debt can be reduced.

From revenue to earnings

BASF stock is therefore best understood as a transition story inside a cyclical sector, with revenue, EBITDA, and cash flow all pointing to the same execution test. The 2025 results do not rely on one eye-catching line; they show a broad mix of pressure and improvement.

Sales slipped from EUR 68.9 billion to EUR 65.3 billion, EBITDA before special items moved from EUR 8.0 billion to EUR 7.9 billion, and net income increased from EUR 225 million to EUR 1.3 billion. That spread is why the earnings base matters more than a simple top-line read.

What the numbers imply

For the market, the implied question is whether BASF can defend the 12.1% EBITDA margin before special items while keeping free cash flow positive. The answer will shape how investors treat the next set of company updates more than any broad sector narrative.

On the evidence already published, BASF stock sits on a measurable base: EUR 65.3 billion of sales, EUR 7.9 billion of EBITDA before special items, EUR 0.7 billion of free cash flow, and EUR 15.1 billion of net debt. Those are the figures that define the current setup.

BASF company data

• Company: BASF SE
• ISIN: DE000BASF111
• WKN: BASF11
• Ticker: XETRA: BAS
• Trading venue: Xetra
• Sector / Industry: Materials / Specialty Chemicals
• Index membership: DAX

Market note

BASF shares on Xetra remain tied to the latest published operating base and the next investor update from the company.